Home > News > Fujifilm Focuses on Pharma
March 24th, 2008
Abstract:
With film fading into the background, the company wants to apply its production expertise and nanotechnology techniques to drugmaking
What do drugs have in common with the $28 billion company's longtime business in photo film? More than you might think, according to Komori. Fujifilm wants to apply both its production expertise and nanotechnology techniques, originally developed for film production, to drugmaking. One example that predates the Toyama deal: an experimental cancer treatment that's made from microscopic particles like those in gelatin coatings on film and that's spread on skin like an ointment. Selling pharmaceuticals complements Fujifilm's existing businesses in gene analysis and imaging technology for ultrasound and X-ray machines, Komori told the Japanese financial daily Nikkei in early March.
Source:
businessweek.com
Related News Press |
News and information
Simulating magnetization in a Heisenberg quantum spin chain April 5th, 2024
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||